AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Identifying which cards provide unlimited cash back options can enhance your rewards. Find the best choices for your spending!
26,576 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
SpaceX raised $25 billion through a bond offering that received top ratings from credit agencies, yet the stock still...
A surprise accounting disclosure sent Driven Brands shares skidding. This guide breaks down what happened, how to ass...
Get ready for the genk 2025 earnings call with a clear game plan. This guide breaks down what to listen for, how to r...
Palantir has a large revenue backlog, a major Army contract on the books, and ambitious growth guidance. This analysi...
Amazon's latest move highlights a broader theme: AI investment can lift near-term costs even as revenue opportunities...
Markets in May 2026 present an unusually wide yield spectrum as geopolitical tensions and a steady Fed backdrop resha...
A 68-year-old couple has relied on an 8% yield from a long-held closed-end fund for over a decade, sparking debate am...
Midweek market noise can overwhelm your plan. This Wednesday Reads guide distills 10 essential investing topics into ...
A $500,000 roth portfolio loaded with JEPI could generate about $42,000 in annual distributions tax-free, underscorin...
A resurfaced teen photo sparked online backlash for Hudson Williams, highlighting how reputational events can ripple ...
June brought a tech-led rally as Marvell Technology jumped on a price target upgrade. This piece breaks down the move...